Loading...

Purified anti-mouse CD3ε Antibody Purified anti-mouse CD3ε Antibody

Pricing & Availability
Clone
145-2C11 (See other available formats)
Regulatory Status
RUO
Other Names
CD3ε, T3, CD3
Isotype
Armenian Hamster IgG
Ave. Rating
Submit a Review
Product Citations
publications
145-2C11_Pure_021606
C57BL/6 mouse splenocytes were stained with purified CD3e (clone 145-2C11) (filled histogram) or Armenian hamster IgG isotype control (open histogram), followed by anti-Armenian hamster IgG FITC.
  • 145-2C11_Pure_021606
    C57BL/6 mouse splenocytes were stained with purified CD3e (clone 145-2C11) (filled histogram) or Armenian hamster IgG isotype control (open histogram), followed by anti-Armenian hamster IgG FITC.
  • 145-2C11_PURE_CD3e_Antibody_IHC-F_033017
    C57BL/6 mouse frozen spleen section was fixed with 4% paraformaldehyde (PFA) for ten minutes at room temperature and blocked with 5% FBS for 30 minutes at room temperature. Then the section was stained with 10 µg/mL of purified anti-mouse CD3ε (clone 145-2C11) and 10 µg/mL of Alexa Fluor® 488 anti-mouse/human CD45R/B220 (clone RA3-6B2) (green) overnight at 4°C, followed by 2.5 µg/mL of Alexa Fluor® 594 Goat anti-hamster (Armenian) IgG (clone Poly4055) (red) for two hours at room temperature. The image was captured by 10X objective.
  • 145-2C11_PURE_CD3e_Antibody_IHC-F_2_102518
    Fresh, frozen mouse spleen was stained with purified CD3ε clone 145-2C11 conjugated and detected with a Cy3 CODEX™ oligonucleotide duplex (red). Samples were counterstained with B220 A647 (green). Data generated at Akoya Biosciences, Inc. using the CODEX™ technology.
Compare all formats
Cat # Size Price Quantity Check Availability Save
100301 50 µg NOK198
Check Availability


Need larger quantities of this item?
Request Bulk Quote
100302 500 µg NOK594
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD3ε is a 20 kD transmembrane protein, also known as CD3 or T3. It is a member of the Ig superfamily and primarily expressed on T cells, NK-T cells, and at different levels on thymocytes during T cell differentiation. CD3ε forms a TCR complex by associating with the CD3δ, γ and ζ chains, as well as the TCR α/β or γ/δ chains. CD3 plays a critical role in TCR signal transduction, T cell activation, and antigen recognition by binding the peptide/MHC antigen complex.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Armenian Hamster
Immunogen
H-2Kb-specific mouse cytotoxic T lymphocyte clone BM10-37
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography.
Concentration
0.5 mg/ml
Storage & Handling
The CD3ε antibody solution should be stored undiluted between 2°C and 8°C.
Application

FC - Quality tested
IHC-F - Verified
IP, Activ, Block, WB, ICC - Reported in the literature, not verified in house
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 1.0 µg per million cells in 100 µl volume. For immunohistochemical staining on frozen tissue sections, the suggested use of this reagent is 5.0 - 10 µg per ml. It is recommended that the reagent be titrated for optimal performance for each application.

Application Notes

Clone 145-2C11 is useful for in vitro blocking of target-specific CTL-mediated cell lysis1, as well as T cell activation assays, inducing proliferation and cytokine production1,2,7,12,16. It also induces apoptosis in immature thymocytes32,  and in vivo T cell depletion8-10. Additional reported applications (for relevant formats of this clone) include: immunoprecipitation1, immunohistochemical staining14,15 of acetone-fixed frozen sections and zinc-fixed paraffin-embedded sections, Western blotting4, complement-mediated cytotoxicity6, in vitro and in vivo stimulation of T cells1,2,7,12,16, immunofluorescent staining5, and in vivo T cell depletion8-10. The 145-2C11 antibody has been reported to block the binding of 17A2 antibody to CD3 epsilon-specific T cells11. Clone 145-2C11 is not recommended for formalin-fixed paraffin embedded sections. The LEAF™ purified antibody (Endotoxin <0.1 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays (Cat. No. 100314). For in vivo studies or highly sensitive assays, we recommend Ultra-LEAF™ purified antibody (Cat. No. 100340) with a lower endotoxin limit than standard LEAF™ purified antibodies (Endotoxin <0.01 EU/µg).

Application References
  1. Leo O, et al. 1987. P. Natl. Acad. Sci. USA 84:1374. (IP, Activ, Block)
  2. Kruisbeek AM, et al. 1991. In Current Protocols in Immunology. 3.12.1. (Activ)
  3. Duke RC, et al. 1995. Current Protocols in Immunology. 3.17.1.
  4. Salvadori S, et al. 1994. J. Immunol. 153:5176. (WB)
  5. Payer E, et al. 1991. J. Immunol. 146:2536. (IF)
  6. Jacobs H, et al. 1994. Eur. J. Immunol. 24:934. (CMCD)
  7. Vossen ACTM, et al. 1995. Eur. J. Immunol. 25:1492. (Activ)
  8. Henrickson M, et al. 1995. Transplantation 60:828. (Deplete)
  9. Kinnaert P, et al. 1996. Transpl. Int. 9:386. (Deplete)
  10. Han WR, et al. 1999. Transpl. Immunol. 7:207. (Deplete)
  11. Miescher GC, et al. 1989. Immunol. Lett. 23:113. (Block)
  12. Terrazas LI, et al. 2005. Intl. J. Parasitology. 35:1349. (Activ)
  13. Ko SY, et al. 2005. J. Immunol. 175:3309.
  14. Podd BS, et al. 2006. J. Immunol. 176:6532. (IHC-F)
  15. Tilley SL, et al. 2007. J. Immunol. 178:3208. (IHC-F)
  16. Wang W, et al. 2007. J. Immunol. 178:4885. (Activ)
  17. Xiao S, et al. 2007. J. Exp. Med. 204:1691.
  18. Chappaz S, et al. 2007. Blood doi:10.1182/blood-2007-02-074245. (FC) PubMed.
  19. Curtsinger JM, et al.2005. J. Immunol. 175:4392. PubMed
  20. Guo Y, et al. 2008. Blood 112:480. PubMed
  21. Kenna TJ, et al. 2008. Blood 111:2091.
  22. Perchonock CE, et al. 2007. J. Immunol. 179:1768. PubMed
  23. Perchonock GE, et al. 2006. Mol. Cell. Biol. 26:6005. PubMed
  24. Kanaya T, et al. 2008. Am. J. Physiol. Gastrointest. Liver Physiol. 295:G273. PubMed
  25. de Koning BA, et al. 2006. Int. Immunol. 18:941. PubMed
  26. Schulteis RD, et al. 2008. Blood 295:G273. PubMed
  27. Qi Q, et al. 2009. Blood 114:564. PubMed
  28. Helmersson S, et al. 2013. Am J Pathol. 9440:123. Pubmed
  29. Wu S, et al. 2014. Clin Vaccine Immunol. 21:156. PubMed
  30. Yan J, et al. 2014. Vaccine. 32:2833. PubMed
  31. Guiterrez DA, et al. 2014. Diaebetes. 63:3827. PubMed
  32. Shi YF, et al. 1991. J Immunol. 146:3340. (Apop)
Product Citations
  1. Kim K, et al. 2016. PLoS One. 11: 0148576. PubMed
  2. Chemnitz J, et al. 2019. Sci Rep. 3.745138889. PubMed
  3. Arnold IC, et al. 2019. PLoS Pathog. 15:e1007866. PubMed
  4. Wolf Y, et al. 2017. J Exp Med. 214:905. PubMed
  5. Akiyama C, et al. 2019. J Immunol. 203:835. PubMed
  6. Bergfeld A, et al. 2017. Front Microbiol. 0.919444444. PubMed
  7. Liu CJ, et al. 2020. Neuro Oncol. 22:1276. PubMed
  8. Collin R, et al. 2020. J Immunol. 205:133. PubMed
  9. Malinczak CA, et al. 2021. J Immunol. 206:1315. PubMed
  10. Li H, et al. 2022. Cancer Cell. 40:36. PubMed
  11. Koenig A, et al. 2022. Front Immunol. 12:791100. PubMed
  12. Zhu M, et al. 2022. Front Immunol. 13:1019248. PubMed
  13. Briukhovetska D, et al. 2023. Immunity. 56:143. PubMed
  14. Zhang J, et al. 2023. Int J Nanomedicine. 18:209. PubMed
  15. Elliot TAE, et al. 2022. Discov Immunol. 1:kyac009. PubMed
  16. Schick J, et al. 2023. Elife. 12: . PubMed
  17. Shirai T, et al. 2022. Cancer Sci. 113:3710. PubMed
  18. Giampaolo S, et al. 2023. iScience. 26:106234. PubMed
  19. Do-Thi VA, et al. 2023. Cancer Res Commun. 3:80. PubMed
  20. Kobayashi A, et al. 2021. Front Immunol. 12:650856. PubMed
  21. Paterson MJ, et al. 2020. PLoS Pathog. 16:e1008733. PubMed
  22. Tian J, et al. 2021. Autophagy. 17:2586. PubMed
  23. Tersteegen A, et al. 2021. Infect Immun. 89:. PubMed
  24. Sandu I, et al. 2020. Nat Commun. 11:4454. PubMed
  25. Krovi SH, et al. 2019. Proc Natl Acad Sci U S A. 116:22252. PubMed
  26. Biljes D, et al. 2017. EXCLI J. 0.86875. PubMed
  27. Chartrand K, et al. 2018. Front Immunol. 1.642361111. PubMed
  28. Kondo H, et al. 2020. J Biol Chem. 295:1658. PubMed
  29. Wan Mohd Zawawi WFA, et al. 2021. Sci Rep. 11:10278. PubMed
  30. Boyd DF, et al. 2020. Nature. 587:466. PubMed
  31. Field CS, et al. 2018. Oncoimmunology. 7:e1376154. PubMed
  32. Namavari A, et al. 2012. Invest Ophthalmol Vis Sci . 53:4575. PubMed
  33. Goel S, et al. 2017. Nature. 548:471. PubMed
  34. Prado C, et al. 2021. J Neuroinflammation. 18:292. PubMed
  35. Uzhachenko RV, et al. 2021. Cell Reports. 35(1):108944. PubMed
  36. Chen L, et al. 2019. Nat Commun. 3.553472222. PubMed
  37. Sanctuary MR, et al. 2019. Mucosal Immunol. 0.638888889. PubMed
  38. Carpenter SM, et al. 2017. PLoS Pathog. 13:e1006704. PubMed
  39. Wong E, et al. 2019. Cell Rep. 29:3047. PubMed
  40. Crawford G, et al. 2018. Nat Immunol. 1.388194444. PubMed
  41. Cao Q, et al. 2018. Am J Physiol Renal Physiol. 314:F561. PubMed
  42. Oghumu S, et al. 2019. J Immunol. 203:789. PubMed
  43. Liang W, et al. 2022. Methods Mol Biol. 2574:221. PubMed
  44. Nagatake T, et al. 2022. Mucosal Immunol. 15:289. PubMed
  45. McLane LM, et al. 2021. Cell Reports. 35(6):109120. PubMed
  46. Niss Arfelt K, et al. 2017. Blood. 129:866. PubMed
  47. Arimura K, et al. 2017. Mucosal Immunol. 1.08125. PubMed
  48. Zhou AC, et al. 2017. Front Immunol. 1.136111111. PubMed
  49. Willimsky G, et al. 2021. Elife. 10:. PubMed
  50. Quintana E, et al. 2020. Cancer Res. 80:2889. PubMed
  51. Jennings EK, et al. 2021. STAR Protocols. 2(1):100284. PubMed
  52. Lu SX, et al. 2021. Cell. . PubMed
  53. Liu W, et al. 2021. Stem Cell Res Ther. 12:153. PubMed
  54. Joseph R, et al. 2021. Br J Cancer. 125:176. PubMed
  55. Edenborough KM, et al. 2019. Front Immunol. 10:2414. PubMed
  56. McLeod RL, et al. 2018. Oncotarget. 9:34459. PubMed
  57. Robert S, et al. 2018. Bone Marrow Transplant. 53:807. PubMed
  58. Morabito KM, et al. 2017. Mucosal Immunol. 0.795138889. PubMed
  59. Rissiek B, et al. 2017. Sci Rep. . 10.1038/s41598-017-16613-w. PubMed
  60. Delgobo M, et al. 2021. Front Immunol. 12:584538. PubMed
  61. Peng V, et al. 2020. J Biol Chem. 295:14866. PubMed
  62. Tanaka Y, et al. 2021. Int J Mol Sci. 22:. PubMed
  63. Muhammad F, et al. 2020. Front Immunol. 975:11. PubMed
  64. Yi M, et al. 2021. J Hematol Oncol. 14:27. PubMed
  65. Rao TN, et al. 2020. J Immunol. 204:2600. PubMed
  66. Perchonock C, et al. 2006. Mol Cell Biol . 26:6005. PubMed
  67. Guo Y, et al. 2008. Blood. 112:480. PubMed
  68. Sekiya T et al. 2018. Cell reports. 24(6):1627-1638 . PubMed
  69. Lyon de Ana C, et al. 2019. J Immunol. 202:1112. PubMed
  70. Wu P et al. 2019. Molecular cell. 73(5):1015-1027 . PubMed
  71. Tuzlak S, et al. 2017. Cell Death Differ. 24:523. PubMed
  72. Doorduijn EM, et al. 2018. Front Immunol. 0.416666667. PubMed
  73. Baluk P, et al. 2020. Am J Pathol. 190:2355. PubMed
  74. Mullins GN, et al. 2020. Sci Rep. 10:21994. PubMed
  75. Hilligan KL, et al. 2020. Nat Commun. 11:5637. PubMed
  76. Suzuki Y, et al. 2021. FEBS Open Bio. 11:2619. PubMed
  77. El Maï M, et al. 2021. Cancers (Basel). 13:. PubMed
  78. Hanoteau A, et al. 2019. J Immunother Cancer. 7:10. PubMed
  79. Stacey MA, et al. 2017. J Clin Invest. 127:1463. PubMed
  80. Duc D et al. 2019. Cell Rep. 29(2):378-390 . PubMed
  81. Xu L et al. 2017. Immunity. 47(3):538-551 . PubMed
  82. Zhang P, et al. 2022. BMC Med. 20:435. PubMed
  83. McCully M, et al. 2015. J Immunol. 195: 96 - 104. PubMed
  84. Bremser A, et al. 2015. PLoS One. 10: 0137393. PubMed
  85. Gartlan KH, et al. 2019. Blood Adv. 2.110416667. PubMed
  86. Abboud G, et al. 2018. Front Immunol. 9:1973. PubMed
  87. Chen Z et al. 2019. Immunity. 51(5):840-855 . PubMed
  88. Imani J, et al. 2021. JCI Insight. 6:. PubMed
  89. Xie D, et al. 2020. Eur J Immunol. 50:1729. PubMed
  90. Reed J, et al. 2020. Bio Protoc. 10:e3607. PubMed
  91. Morales-Mantilla DE, et al. 2022. Elife. 11:. PubMed
  92. Brown IK, et al. 2021. PLoS Pathog. 17:e1009602. PubMed
  93. Cain MP, et al. 2020. Dis Model Mech. 13:00. PubMed
  94. Takushi SE, et al. 2020. Hum Gene Ther. 31:626. PubMed
  95. Borges TJ, et al. 2018. Nat Commun. 9:3482. PubMed
  96. Di Martino L, et al. 2021. Cell Mol Gastroenterol Hepatol. 13:901. PubMed
  97. James OJ, et al. 2021. Nat Commun. 12:4290. PubMed
  98. Sharabi A, et al. 2019. JCI Insight. 4:e126294. PubMed
  99. Du J, et al. 2018. AMB Express. 8:158. PubMed
  100. Majer O, et al. 2019. Nature. 575:366. PubMed
  101. Won HY, et al. 2017. Sci Rep. 7:16946. PubMed
  102. Van De Velde LA, et al. 2017. J Biol Chem. 292:15:00. PubMed
  103. Scholz T, et al. 2017. PLoS One. 12:e0182646. PubMed
  104. Sprouse ML, et al. 2018. JCI Insight. 3:e97322. PubMed
  105. Lee JY, et al. 2018. Front Immunol. 0.678472222. PubMed
  106. Sun L, et al. 2022. Front Immunol. 13:823853. PubMed
  107. Wu G, et al. 2022. Wellcome Open Res. 6:134. PubMed
  108. Otsuka S, et al. 2021. J Clin Invest. 131:. PubMed
  109. Schuler CF, et al. 2020. Allergy. 75:2279. PubMed
  110. Yoon S, et al. 2020. Antioxidants (Basel). 10:. PubMed
  111. Tao H, et al. 2021. Front Immunol. 12:623280. PubMed
  112. Hsieh WC, et al. 2020. JCI Insight. 5:00. PubMed
  113. Sharma M, et al. 2020. Circ Res. 127:335. PubMed
  114. Seo N, et al. 2018. Nat Commun. 9:435. PubMed
  115. Parzmair GP, et al. 2017. J Leukoc Biol. 101:407. PubMed
  116. Kälin S et al. 2017. Cell metabolism. 26(3):475-492 . PubMed
  117. Simula L et al. 2018. Cell reports. 25(11):3059-3073 . PubMed
  118. Nagatake T, et al. 2018. Int Immunol. 30:471. PubMed
  119. Hao Y, et al. 2018. Front Immunol. 9:1127. PubMed
  120. Ma VP, et al. 2022. Sci Adv. 8:eabg4485. PubMed
  121. Li Z, et al. 2021. MBio. 12:e0254221. PubMed
  122. Ejima R, et al. 2021. Nutrients. 13:. PubMed
  123. Becker W, et al. 2021. J Crohns Colitis. 15:1032. PubMed
  124. Chen HW, et al. 2021. Biomedicines. 9:. PubMed
  125. Sandy A, et al. 2013. J Immunol. 190:5818. PubMed
  126. Klein JC, et al. 2017. Nat Commun. 8:14600. PubMed
  127. Baluk P, et al. 2018. Methods Mol Biol. 1846:161. PubMed
  128. Katagiri T, et al. 2019. Mucosal Immunol. 12:p1104. PubMed
  129. Wang HC, et al. 2017. J Immunol. 198:3149. PubMed
  130. Parigi SM, et al. 2018. Sci Rep. 0.440277778. PubMed
  131. Shiozawa S, et al. 2022. iScience. 25:103537. PubMed
  132. Wu Y, et al. 2021. J Clin Invest. 131:. PubMed
  133. Rigo MM, et al. 2020. FEBS J. :. PubMed
  134. Sripada A, et al. 2021. PLoS Biol. 19:e3001063. PubMed
  135. Spranger S, et al. 2017. Cancer Cell. 31:711. PubMed
  136. Wang W, et al. 2018. J Vasc Surg. 68:1538. PubMed
  137. Nagatake T, et al. 2018. J Allergy Clin Immunol. 142:470. PubMed
  138. Lee J, et al. 2020. Cells. 9:. PubMed
  139. Seo SU, et al. 2021. Front Immunol. 12:697162. PubMed
  140. Goh W, et al. 2020. Cell Rep. 33:108285. PubMed
  141. Teijeira A, et al. 2018. Cancer Immunol Res. 6:798. PubMed
  142. Jiao S, et al. 2020. Cell. 179(5):1177-1190.e13.. PubMed
  143. Link MA, et al. 2017. PLoS One. 12:e0184320. PubMed
  144. Aguilar OA, et al. 2020. J Immunol. 205:1709. PubMed
  145. Taylor MD, et al. 2020. Front Immunol. 11:1946. PubMed
  146. Kissiov DU, et al. 2022. Elife. 11:. PubMed
  147. Yoon S, et al. 2022. Nat Commun. 13:1602. PubMed
  148. Fernández-Orth J, et al. 2020. Eur J Immunol. . PubMed
  149. Wagner AK, et al. 2017. Nat Commun. 8:15627. PubMed
  150. Stelekati E, et al. 2018. Cell Rep. 2.445833333. PubMed
  151. Cui X, et al. 2017. J Immunol. 199:4066. PubMed
  152. Simmons S et al. 2019. Elife. 8 pii: e41239. PubMed
  153. Niven J, et al. 2019. Cell Rep. 28:21. PubMed
  154. Coley WD et al. 2018. F1000Research. 2018 Mar 14 [revised 2018 Jan 1] 0.5125. PubMed
  155. Koch K, et al. 2022. Int J Mol Sci. 23:. PubMed
  156. Yang H, et al. 2022. Cell Death Discov. 8:183. PubMed
  157. Qiu Z, et al. 2022. Cancer Discov. 12:502. PubMed
  158. Sun Y, et al. 2021. Nat Commun. 12:5147. PubMed
  159. Lin Z, et al. 2021. Stem Cells. 39:240. PubMed
  160. Chen Z, et al. 2021. Cell. 184(5):1262-1280.e22. PubMed
  161. Gaspar M, et al. 2020. Cancer Immunol Res. 0.875694444. PubMed
  162. Afzali B, et al. 2017. Nat Immunol. 18:813. PubMed
  163. Cohen MA, et al. 2020. Cell Stem Cell. 26(4):579-592. PubMed
  164. Genoud V, et al. 2018. Oncoimmunology. 7:e1501137. PubMed
  165. Gaya M et al. 2018. Cell. 172(3):517-533 . PubMed
  166. Schnoegl D, et al. 2022. Front Immunol. 13:909270. PubMed
  167. Dey P, et al. 2020. Cancer Discov. 10:608. PubMed
  168. Perchonock C, et al. 2007. J Immunol. 179:1768. PubMed
  169. Cole C, et al. 2018. Nucleic Acids Res. 46:e62. PubMed
  170. Abe Y, et al. 2017. Biochem Biophys Rep. 0.543055556. PubMed
  171. Nakamura K, et al. 2018. Cancer Cell. 33:634. PubMed
  172. Lin J, et al. 2017. Nat Commun. . 10.1038/s41467-017-01477-5. PubMed
  173. Taylor MD, et al. 2020. Front Immunol. 11:563402. PubMed
  174. Nagatake T, et al. 2021. Int Immunol. 33:171. PubMed
  175. Sasai M, et al. 2021. J Exp Med. 218:. PubMed
  176. Wang G, et al. 2015. PLoS One. 10:121968. PubMed
  177. Kojima T, et al. 2016. Sci Rep. 6:36457. PubMed
  178. Khameneh HJ, et al. 2017. J Immunol. 198:196. PubMed
  179. Wang N, et al. 2020. Front Immunol. 1.765972222. PubMed
  180. An Y et al. 2018. Cell reports. 25(3):702-714 . PubMed
  181. Kikuchi K, et al. 2018. J Immunol. 201:635. PubMed
  182. Akkaya B, et al. 2018. J Immunol. 201:3294. PubMed
  183. Bordoloi D, et al. 2021. Genes Cancer. 12:51. PubMed
  184. Wang W, et al. 2022. Nat Commun. 13:4495. PubMed
  185. Katsuyama T, et al. 2021. Cell Reports. 36(1):109339. PubMed
  186. Kästle M, et al. 2020. Cell Commun Signal. 183:18. PubMed
  187. Fritz Y, et al. 2017. J Invest Dermatol. 137:696. PubMed
  188. Umeda M, et al. 2021. Proc Natl Acad Sci U S A. 118:. PubMed
  189. Prabakaran T, et al. 2021. EBioMedicine. 66:103314. PubMed
  190. Yamazaki K, et al. 2022. Sci Rep. 12:3242. PubMed
  191. Chen YH, et al. 2022. Arthritis Res Ther. 24:27. PubMed
  192. Sutiwisesak R, et al. 2020. PLoS Pathog. 16:e1009000. PubMed
  193. Xia L, et al. 2021. Cancer Immunol Res. 9:707. PubMed
  194. Galeano Nio JL, et al. 2020. eLife. 9:00. PubMed
  195. Kim K, et al. 2016. PLoS One. 11: 0148576. PubMed
  196. Chemnitz J, et al. 2019. Sci Rep. 3.745138889. PubMed
  197. Arnold IC, et al. 2019. PLoS Pathog. 15:e1007866. PubMed
  198. Wolf Y, et al. 2017. J Exp Med. 214:905. PubMed
  199. Akiyama C, et al. 2019. J Immunol. 203:835. PubMed
  200. Bergfeld A, et al. 2017. Front Microbiol. 0.919444444. PubMed
  201. Liu CJ, et al. 2020. Neuro Oncol. 22:1276. PubMed
  202. Collin R, et al. 2020. J Immunol. 205:133. PubMed
  203. Malinczak CA, et al. 2021. J Immunol. 206:1315. PubMed
  204. Li H, et al. 2022. Cancer Cell. 40:36. PubMed
  205. Koenig A, et al. 2022. Front Immunol. 12:791100. PubMed
  206. Zhu M, et al. 2022. Front Immunol. 13:1019248. PubMed
  207. Briukhovetska D, et al. 2023. Immunity. 56:143. PubMed
  208. Zhang J, et al. 2023. Int J Nanomedicine. 18:209. PubMed
  209. Elliot TAE, et al. 2022. Discov Immunol. 1:kyac009. PubMed
  210. Schick J, et al. 2023. Elife. 12: . PubMed
  211. Shirai T, et al. 2022. Cancer Sci. 113:3710. PubMed
  212. Giampaolo S, et al. 2023. iScience. 26:106234. PubMed
  213. Do-Thi VA, et al. 2023. Cancer Res Commun. 3:80. PubMed
  214. Kobayashi A, et al. 2021. Front Immunol. 12:650856. PubMed
  215. Paterson MJ, et al. 2020. PLoS Pathog. 16:e1008733. PubMed
  216. Tian J, et al. 2021. Autophagy. 17:2586. PubMed
  217. Tersteegen A, et al. 2021. Infect Immun. 89:. PubMed
  218. Sandu I, et al. 2020. Nat Commun. 11:4454. PubMed
  219. Krovi SH, et al. 2019. Proc Natl Acad Sci U S A. 116:22252. PubMed
  220. Biljes D, et al. 2017. EXCLI J. 0.86875. PubMed
  221. Chartrand K, et al. 2018. Front Immunol. 1.642361111. PubMed
  222. Kondo H, et al. 2020. J Biol Chem. 295:1658. PubMed
  223. Wan Mohd Zawawi WFA, et al. 2021. Sci Rep. 11:10278. PubMed
  224. Boyd DF, et al. 2020. Nature. 587:466. PubMed
  225. Field CS, et al. 2018. Oncoimmunology. 7:e1376154. PubMed
  226. Namavari A, et al. 2012. Invest Ophthalmol Vis Sci . 53:4575. PubMed
  227. Goel S, et al. 2017. Nature. 548:471. PubMed
  228. Prado C, et al. 2021. J Neuroinflammation. 18:292. PubMed
  229. Uzhachenko RV, et al. 2021. Cell Reports. 35(1):108944. PubMed
  230. Chen L, et al. 2019. Nat Commun. 3.553472222. PubMed
  231. Sanctuary MR, et al. 2019. Mucosal Immunol. 0.638888889. PubMed
  232. Carpenter SM, et al. 2017. PLoS Pathog. 13:e1006704. PubMed
  233. Wong E, et al. 2019. Cell Rep. 29:3047. PubMed
  234. Crawford G, et al. 2018. Nat Immunol. 1.388194444. PubMed
  235. Cao Q, et al. 2018. Am J Physiol Renal Physiol. 314:F561. PubMed
  236. Oghumu S, et al. 2019. J Immunol. 203:789. PubMed
  237. Liang W, et al. 2022. Methods Mol Biol. 2574:221. PubMed
  238. Nagatake T, et al. 2022. Mucosal Immunol. 15:289. PubMed
  239. McLane LM, et al. 2021. Cell Reports. 35(6):109120. PubMed
  240. Niss Arfelt K, et al. 2017. Blood. 129:866. PubMed
  241. Arimura K, et al. 2017. Mucosal Immunol. 1.08125. PubMed
  242. Zhou AC, et al. 2017. Front Immunol. 1.136111111. PubMed
  243. Willimsky G, et al. 2021. Elife. 10:. PubMed
  244. Quintana E, et al. 2020. Cancer Res. 80:2889. PubMed
  245. Jennings EK, et al. 2021. STAR Protocols. 2(1):100284. PubMed
  246. Lu SX, et al. 2021. Cell. . PubMed
  247. Liu W, et al. 2021. Stem Cell Res Ther. 12:153. PubMed
  248. Joseph R, et al. 2021. Br J Cancer. 125:176. PubMed
  249. Edenborough KM, et al. 2019. Front Immunol. 10:2414. PubMed
  250. McLeod RL, et al. 2018. Oncotarget. 9:34459. PubMed
  251. Robert S, et al. 2018. Bone Marrow Transplant. 53:807. PubMed
  252. Morabito KM, et al. 2017. Mucosal Immunol. 0.795138889. PubMed
  253. Rissiek B, et al. 2017. Sci Rep. . 10.1038/s41598-017-16613-w. PubMed
  254. Delgobo M, et al. 2021. Front Immunol. 12:584538. PubMed
  255. Peng V, et al. 2020. J Biol Chem. 295:14866. PubMed
  256. Tanaka Y, et al. 2021. Int J Mol Sci. 22:. PubMed
  257. Muhammad F, et al. 2020. Front Immunol. 975:11. PubMed
  258. Yi M, et al. 2021. J Hematol Oncol. 14:27. PubMed
  259. Rao TN, et al. 2020. J Immunol. 204:2600. PubMed
  260. Perchonock C, et al. 2006. Mol Cell Biol . 26:6005. PubMed
  261. Guo Y, et al. 2008. Blood. 112:480. PubMed
  262. Sekiya T et al. 2018. Cell reports. 24(6):1627-1638 . PubMed
  263. Lyon de Ana C, et al. 2019. J Immunol. 202:1112. PubMed
  264. Wu P et al. 2019. Molecular cell. 73(5):1015-1027 . PubMed
  265. Tuzlak S, et al. 2017. Cell Death Differ. 24:523. PubMed
  266. Doorduijn EM, et al. 2018. Front Immunol. 0.416666667. PubMed
  267. Baluk P, et al. 2020. Am J Pathol. 190:2355. PubMed
  268. Mullins GN, et al. 2020. Sci Rep. 10:21994. PubMed
  269. Hilligan KL, et al. 2020. Nat Commun. 11:5637. PubMed
  270. Suzuki Y, et al. 2021. FEBS Open Bio. 11:2619. PubMed
  271. El Maï M, et al. 2021. Cancers (Basel). 13:. PubMed
  272. Hanoteau A, et al. 2019. J Immunother Cancer. 7:10. PubMed
  273. Stacey MA, et al. 2017. J Clin Invest. 127:1463. PubMed
  274. Duc D et al. 2019. Cell Rep. 29(2):378-390 . PubMed
  275. Xu L et al. 2017. Immunity. 47(3):538-551 . PubMed
  276. Zhang P, et al. 2022. BMC Med. 20:435. PubMed
  277. McCully M, et al. 2015. J Immunol. 195: 96 - 104. PubMed
  278. Bremser A, et al. 2015. PLoS One. 10: 0137393. PubMed
  279. Gartlan KH, et al. 2019. Blood Adv. 2.110416667. PubMed
  280. Abboud G, et al. 2018. Front Immunol. 9:1973. PubMed
  281. Chen Z et al. 2019. Immunity. 51(5):840-855 . PubMed
  282. Imani J, et al. 2021. JCI Insight. 6:. PubMed
  283. Xie D, et al. 2020. Eur J Immunol. 50:1729. PubMed
  284. Reed J, et al. 2020. Bio Protoc. 10:e3607. PubMed
  285. Morales-Mantilla DE, et al. 2022. Elife. 11:. PubMed
  286. Brown IK, et al. 2021. PLoS Pathog. 17:e1009602. PubMed
  287. Cain MP, et al. 2020. Dis Model Mech. 13:00. PubMed
  288. Takushi SE, et al. 2020. Hum Gene Ther. 31:626. PubMed
  289. Borges TJ, et al. 2018. Nat Commun. 9:3482. PubMed
  290. Di Martino L, et al. 2021. Cell Mol Gastroenterol Hepatol. 13:901. PubMed
  291. James OJ, et al. 2021. Nat Commun. 12:4290. PubMed
  292. Sharabi A, et al. 2019. JCI Insight. 4:e126294. PubMed
  293. Du J, et al. 2018. AMB Express. 8:158. PubMed
  294. Majer O, et al. 2019. Nature. 575:366. PubMed
  295. Won HY, et al. 2017. Sci Rep. 7:16946. PubMed
  296. Van De Velde LA, et al. 2017. J Biol Chem. 292:15:00. PubMed
  297. Scholz T, et al. 2017. PLoS One. 12:e0182646. PubMed
  298. Sprouse ML, et al. 2018. JCI Insight. 3:e97322. PubMed
  299. Lee JY, et al. 2018. Front Immunol. 0.678472222. PubMed
  300. Sun L, et al. 2022. Front Immunol. 13:823853. PubMed
  301. Wu G, et al. 2022. Wellcome Open Res. 6:134. PubMed
  302. Otsuka S, et al. 2021. J Clin Invest. 131:. PubMed
  303. Schuler CF, et al. 2020. Allergy. 75:2279. PubMed
  304. Yoon S, et al. 2020. Antioxidants (Basel). 10:. PubMed
  305. Tao H, et al. 2021. Front Immunol. 12:623280. PubMed
  306. Hsieh WC, et al. 2020. JCI Insight. 5:00. PubMed
  307. Sharma M, et al. 2020. Circ Res. 127:335. PubMed
  308. Seo N, et al. 2018. Nat Commun. 9:435. PubMed
  309. Parzmair GP, et al. 2017. J Leukoc Biol. 101:407. PubMed
  310. Kälin S et al. 2017. Cell metabolism. 26(3):475-492 . PubMed
  311. Simula L et al. 2018. Cell reports. 25(11):3059-3073 . PubMed
  312. Nagatake T, et al. 2018. Int Immunol. 30:471. PubMed
  313. Hao Y, et al. 2018. Front Immunol. 9:1127. PubMed
  314. Ma VP, et al. 2022. Sci Adv. 8:eabg4485. PubMed
  315. Li Z, et al. 2021. MBio. 12:e0254221. PubMed
  316. Ejima R, et al. 2021. Nutrients. 13:. PubMed
  317. Becker W, et al. 2021. J Crohns Colitis. 15:1032. PubMed
  318. Chen HW, et al. 2021. Biomedicines. 9:. PubMed
  319. Sandy A, et al. 2013. J Immunol. 190:5818. PubMed
  320. Klein JC, et al. 2017. Nat Commun. 8:14600. PubMed
  321. Baluk P, et al. 2018. Methods Mol Biol. 1846:161. PubMed
  322. Katagiri T, et al. 2019. Mucosal Immunol. 12:p1104. PubMed
  323. Wang HC, et al. 2017. J Immunol. 198:3149. PubMed
  324. Parigi SM, et al. 2018. Sci Rep. 0.440277778. PubMed
  325. Shiozawa S, et al. 2022. iScience. 25:103537. PubMed
  326. Wu Y, et al. 2021. J Clin Invest. 131:. PubMed
  327. Rigo MM, et al. 2020. FEBS J. :. PubMed
  328. Sripada A, et al. 2021. PLoS Biol. 19:e3001063. PubMed
  329. Spranger S, et al. 2017. Cancer Cell. 31:711. PubMed
  330. Wang W, et al. 2018. J Vasc Surg. 68:1538. PubMed
  331. Nagatake T, et al. 2018. J Allergy Clin Immunol. 142:470. PubMed
  332. Lee J, et al. 2020. Cells. 9:. PubMed
  333. Seo SU, et al. 2021. Front Immunol. 12:697162. PubMed
  334. Goh W, et al. 2020. Cell Rep. 33:108285. PubMed
  335. Teijeira A, et al. 2018. Cancer Immunol Res. 6:798. PubMed
  336. Jiao S, et al. 2020. Cell. 179(5):1177-1190.e13.. PubMed
  337. Link MA, et al. 2017. PLoS One. 12:e0184320. PubMed
  338. Aguilar OA, et al. 2020. J Immunol. 205:1709. PubMed
  339. Taylor MD, et al. 2020. Front Immunol. 11:1946. PubMed
  340. Kissiov DU, et al. 2022. Elife. 11:. PubMed
  341. Yoon S, et al. 2022. Nat Commun. 13:1602. PubMed
  342. Fernández-Orth J, et al. 2020. Eur J Immunol. . PubMed
  343. Wagner AK, et al. 2017. Nat Commun. 8:15627. PubMed
  344. Stelekati E, et al. 2018. Cell Rep. 2.445833333. PubMed
  345. Cui X, et al. 2017. J Immunol. 199:4066. PubMed
  346. Simmons S et al. 2019. Elife. 8 pii: e41239. PubMed
  347. Niven J, et al. 2019. Cell Rep. 28:21. PubMed
  348. Coley WD et al. 2018. F1000Research. 2018 Mar 14 [revised 2018 Jan 1] 0.5125. PubMed
  349. Koch K, et al. 2022. Int J Mol Sci. 23:. PubMed
  350. Yang H, et al. 2022. Cell Death Discov. 8:183. PubMed
  351. Qiu Z, et al. 2022. Cancer Discov. 12:502. PubMed
  352. Sun Y, et al. 2021. Nat Commun. 12:5147. PubMed
  353. Lin Z, et al. 2021. Stem Cells. 39:240. PubMed
  354. Chen Z, et al. 2021. Cell. 184(5):1262-1280.e22. PubMed
  355. Gaspar M, et al. 2020. Cancer Immunol Res. 0.875694444. PubMed
  356. Afzali B, et al. 2017. Nat Immunol. 18:813. PubMed
  357. Cohen MA, et al. 2020. Cell Stem Cell. 26(4):579-592. PubMed
  358. Genoud V, et al. 2018. Oncoimmunology. 7:e1501137. PubMed
  359. Gaya M et al. 2018. Cell. 172(3):517-533 . PubMed
  360. Schnoegl D, et al. 2022. Front Immunol. 13:909270. PubMed
  361. Dey P, et al. 2020. Cancer Discov. 10:608. PubMed
  362. Perchonock C, et al. 2007. J Immunol. 179:1768. PubMed
  363. Cole C, et al. 2018. Nucleic Acids Res. 46:e62. PubMed
  364. Abe Y, et al. 2017. Biochem Biophys Rep. 0.543055556. PubMed
  365. Nakamura K, et al. 2018. Cancer Cell. 33:634. PubMed
  366. Lin J, et al. 2017. Nat Commun. . 10.1038/s41467-017-01477-5. PubMed
  367. Taylor MD, et al. 2020. Front Immunol. 11:563402. PubMed
  368. Nagatake T, et al. 2021. Int Immunol. 33:171. PubMed
  369. Sasai M, et al. 2021. J Exp Med. 218:. PubMed
  370. Wang G, et al. 2015. PLoS One. 10:121968. PubMed
  371. Kojima T, et al. 2016. Sci Rep. 6:36457. PubMed
  372. Khameneh HJ, et al. 2017. J Immunol. 198:196. PubMed
  373. Wang N, et al. 2020. Front Immunol. 1.765972222. PubMed
  374. An Y et al. 2018. Cell reports. 25(3):702-714 . PubMed
  375. Kikuchi K, et al. 2018. J Immunol. 201:635. PubMed
  376. Akkaya B, et al. 2018. J Immunol. 201:3294. PubMed
  377. Bordoloi D, et al. 2021. Genes Cancer. 12:51. PubMed
  378. Wang W, et al. 2022. Nat Commun. 13:4495. PubMed
  379. Katsuyama T, et al. 2021. Cell Reports. 36(1):109339. PubMed
  380. Kästle M, et al. 2020. Cell Commun Signal. 183:18. PubMed
  381. Fritz Y, et al. 2017. J Invest Dermatol. 137:696. PubMed
  382. Umeda M, et al. 2021. Proc Natl Acad Sci U S A. 118:. PubMed
  383. Prabakaran T, et al. 2021. EBioMedicine. 66:103314. PubMed
  384. Yamazaki K, et al. 2022. Sci Rep. 12:3242. PubMed
  385. Chen YH, et al. 2022. Arthritis Res Ther. 24:27. PubMed
  386. Sutiwisesak R, et al. 2020. PLoS Pathog. 16:e1009000. PubMed
  387. Xia L, et al. 2021. Cancer Immunol Res. 9:707. PubMed
  388. Galeano Nio JL, et al. 2020. eLife. 9:00. PubMed
RRID
AB_312666 (BioLegend Cat. No. 100301)
AB_312667 (BioLegend Cat. No. 100302)

Antigen Details

Structure
Ig superfamily, forms CD3/TCR complex with CD3δ, γ and ζ subunits and TCR (α/β and γ/δ), 20 kD
Distribution

Thymocytes (differentiation dependent), mature T cells, NK-T cells

Function
TCR signal transduction, T cell activation, antigen recognition
Ligand/Receptor
Peptide antigen/MHC-complex
Cell Type
NKT cells, T cells, Thymocytes, Tregs
Biology Area
Immunology
Molecular Family
CD Molecules, TCRs
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Davis MM. 1990. Annu. Rev. Biochem. 59:475.
3. Weiss A, et al. 1994. Cell 76:263.

Gene ID
12501 View all products for this Gene ID
UniProt
View information about CD3epsilon on UniProt.org

Related FAQs

There are no FAQs for this product.

Other Formats

View All CD3ε Reagents Request Custom Conjugation
Description Clone Applications
PE/Cyanine7 anti-mouse CD3ε 145-2C11 FC
Purified anti-mouse CD3ε (Maxpar® Ready) 145-2C11 FC,CyTOF®
PE/Dazzle™ 594 anti-mouse CD3ε 145-2C11 FC
Brilliant Violet 605™ anti-mouse CD3ε 145-2C11 FC
Brilliant Violet 711™ anti-mouse CD3ε 145-2C11 FC
Brilliant Violet 785™ anti-mouse CD3ε 145-2C11 FC
Brilliant Violet 510™ anti-mouse CD3ε 145-2C11 FC
APC/Fire™ 750 anti-mouse CD3ε 145-2C11 FC
GoInVivo™ Purified anti-mouse CD3ε 145-2C11 FC
APC anti-mouse CD3ε 145-2C11 FC
Biotin anti-mouse CD3ε 145-2C11 FC,IHC-F
FITC anti-mouse CD3ε 145-2C11 FC
PE anti-mouse CD3ε 145-2C11 FC
PE/Cyanine5 anti-mouse CD3ε 145-2C11 FC
Purified anti-mouse CD3ε 145-2C11 FC,IHC-F,IP,Activ,Block,WB,ICC
Alexa Fluor® 488 anti-mouse CD3ε 145-2C11 FC
Alexa Fluor® 647 anti-mouse CD3ε 145-2C11 FC,IHC-F,3D IHC
PerCP anti-mouse CD3ε 145-2C11 FC
PerCP/Cyanine5.5 anti-mouse CD3ε 145-2C11 FC
APC/Cyanine7 anti-mouse CD3ε 145-2C11 FC
Pacific Blue™ anti-mouse CD3ε 145-2C11 FC
Ultra-LEAF™ Purified anti-mouse CD3ε 145-2C11 FC,IHC-F,IP,Activ,Block,WB,ICC
Brilliant Violet 421™ anti-mouse CD3ε 145-2C11 FC,ICC
Spark YG™ 593 anti-mouse CD3 145-2C11 FC
PerCP/Fire™ 780 anti-mouse CD3ε 145-2C11 FC
Brilliant Violet 650™ anti-mouse CD3ε 145-2C11 FC
Brilliant Violet 750™ anti-mouse CD3ε 145-2C11 FC
APC/Fire™ 810 anti-mouse CD3ε Antibody 145-2C11 FC
Spark YG™ 581 anti-mouse CD3ε (Flexi-Fluor™) 145-2C11 FC
Spark NIR™ 685 anti-mouse CD3ε (Flexi-Fluor™) Antibody 145-2C11 FC
PE/Fire™ 640 anti-mouse CD3ε 145-2C11
Go To Top Version: 2    Revision Date: 10.17.2017

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

Pricing & Availability
Clone
145-2C11 (See other available formats)
Regulatory Status
RUO
Other Names
CD3ε, T3, CD3
Isotype
Armenian Hamster IgG
Ave. Rating
Submit a Review
Product Citations
publications
145-2C11_Pure_021606
C57BL/6 mouse splenocytes were stained with purified CD3e (clone 145-2C11) (filled histogram) or Armenian hamster IgG isotype control (open histogram), followed by anti-Armenian hamster IgG FITC.
  • 145-2C11_Pure_021606
    C57BL/6 mouse splenocytes were stained with purified CD3e (clone 145-2C11) (filled histogram) or Armenian hamster IgG isotype control (open histogram), followed by anti-Armenian hamster IgG FITC.
  • 145-2C11_PURE_CD3e_Antibody_IHC-F_033017
    C57BL/6 mouse frozen spleen section was fixed with 4% paraformaldehyde (PFA) for ten minutes at room temperature and blocked with 5% FBS for 30 minutes at room temperature. Then the section was stained with 10 µg/mL of purified anti-mouse CD3ε (clone 145-2C11) and 10 µg/mL of Alexa Fluor® 488 anti-mouse/human CD45R/B220 (clone RA3-6B2) (green) overnight at 4°C, followed by 2.5 µg/mL of Alexa Fluor® 594 Goat anti-hamster (Armenian) IgG (clone Poly4055) (red) for two hours at room temperature. The image was captured by 10X objective.
  • 145-2C11_PURE_CD3e_Antibody_IHC-F_2_102518
    Fresh, frozen mouse spleen was stained with purified CD3ε clone 145-2C11 conjugated and detected with a Cy3 CODEX™ oligonucleotide duplex (red). Samples were counterstained with B220 A647 (green). Data generated at Akoya Biosciences, Inc. using the CODEX™ technology.
Compare all formats
Cat # Size Price Quantity Check Availability Save
100301 50 µg NOK198
Check Availability


Need larger quantities of this item?
Request Bulk Quote
100302 500 µg NOK594
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD3ε is a 20 kD transmembrane protein, also known as CD3 or T3. It is a member of the Ig superfamily and primarily expressed on T cells, NK-T cells, and at different levels on thymocytes during T cell differentiation. CD3ε forms a TCR complex by associating with the CD3δ, γ and ζ chains, as well as the TCR α/β or γ/δ chains. CD3 plays a critical role in TCR signal transduction, T cell activation, and antigen recognition by binding the peptide/MHC antigen complex.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Armenian Hamster
Immunogen
H-2Kb-specific mouse cytotoxic T lymphocyte clone BM10-37
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography.
Concentration
0.5 mg/ml
Storage & Handling
The CD3ε antibody solution should be stored undiluted between 2°C and 8°C.
Application

FC - Quality tested
IHC-F - Verified
IP, Activ, Block, WB, ICC - Reported in the literature, not verified in house
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 1.0 µg per million cells in 100 µl volume. For immunohistochemical staining on frozen tissue sections, the suggested use of this reagent is 5.0 - 10 µg per ml. It is recommended that the reagent be titrated for optimal performance for each application.

Application Notes

Clone 145-2C11 is useful for in vitro blocking of target-specific CTL-mediated cell lysis1, as well as T cell activation assays, inducing proliferation and cytokine production1,2,7,12,16. It also induces apoptosis in immature thymocytes32,  and in vivo T cell depletion8-10. Additional reported applications (for relevant formats of this clone) include: immunoprecipitation1, immunohistochemical staining14,15 of acetone-fixed frozen sections and zinc-fixed paraffin-embedded sections, Western blotting4, complement-mediated cytotoxicity6, in vitro and in vivo stimulation of T cells1,2,7,12,16, immunofluorescent staining5, and in vivo T cell depletion8-10. The 145-2C11 antibody has been reported to block the binding of 17A2 antibody to CD3 epsilon-specific T cells11. Clone 145-2C11 is not recommended for formalin-fixed paraffin embedded sections. The LEAF™ purified antibody (Endotoxin <0.1 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays (Cat. No. 100314). For in vivo studies or highly sensitive assays, we recommend Ultra-LEAF™ purified antibody (Cat. No. 100340) with a lower endotoxin limit than standard LEAF™ purified antibodies (Endotoxin <0.01 EU/µg).

Application References
  1. Leo O, et al. 1987. P. Natl. Acad. Sci. USA 84:1374. (IP, Activ, Block)
  2. Kruisbeek AM, et al. 1991. In Current Protocols in Immunology. 3.12.1. (Activ)
  3. Duke RC, et al. 1995. Current Protocols in Immunology. 3.17.1.
  4. Salvadori S, et al. 1994. J. Immunol. 153:5176. (WB)
  5. Payer E, et al. 1991. J. Immunol. 146:2536. (IF)
  6. Jacobs H, et al. 1994. Eur. J. Immunol. 24:934. (CMCD)
  7. Vossen ACTM, et al. 1995. Eur. J. Immunol. 25:1492. (Activ)
  8. Henrickson M, et al. 1995. Transplantation 60:828. (Deplete)
  9. Kinnaert P, et al. 1996. Transpl. Int. 9:386. (Deplete)
  10. Han WR, et al. 1999. Transpl. Immunol. 7:207. (Deplete)
  11. Miescher GC, et al. 1989. Immunol. Lett. 23:113. (Block)
  12. Terrazas LI, et al. 2005. Intl. J. Parasitology. 35:1349. (Activ)
  13. Ko SY, et al. 2005. J. Immunol. 175:3309.
  14. Podd BS, et al. 2006. J. Immunol. 176:6532. (IHC-F)
  15. Tilley SL, et al. 2007. J. Immunol. 178:3208. (IHC-F)
  16. Wang W, et al. 2007. J. Immunol. 178:4885. (Activ)
  17. Xiao S, et al. 2007. J. Exp. Med. 204:1691.
  18. Chappaz S, et al. 2007. Blood doi:10.1182/blood-2007-02-074245. (FC) PubMed.
  19. Curtsinger JM, et al.2005. J. Immunol. 175:4392. PubMed
  20. Guo Y, et al. 2008. Blood 112:480. PubMed
  21. Kenna TJ, et al. 2008. Blood 111:2091.
  22. Perchonock CE, et al. 2007. J. Immunol. 179:1768. PubMed
  23. Perchonock GE, et al. 2006. Mol. Cell. Biol. 26:6005. PubMed
  24. Kanaya T, et al. 2008. Am. J. Physiol. Gastrointest. Liver Physiol. 295:G273. PubMed
  25. de Koning BA, et al. 2006. Int. Immunol. 18:941. PubMed
  26. Schulteis RD, et al. 2008. Blood 295:G273. PubMed
  27. Qi Q, et al. 2009. Blood 114:564. PubMed
  28. Helmersson S, et al. 2013. Am J Pathol. 9440:123. Pubmed
  29. Wu S, et al. 2014. Clin Vaccine Immunol. 21:156. PubMed
  30. Yan J, et al. 2014. Vaccine. 32:2833. PubMed
  31. Guiterrez DA, et al. 2014. Diaebetes. 63:3827. PubMed
  32. Shi YF, et al. 1991. J Immunol. 146:3340. (Apop)
Product Citations
  1. Kim K, et al. 2016. PLoS One. 11: 0148576. PubMed
  2. Chemnitz J, et al. 2019. Sci Rep. 3.745138889. PubMed
  3. Arnold IC, et al. 2019. PLoS Pathog. 15:e1007866. PubMed
  4. Wolf Y, et al. 2017. J Exp Med. 214:905. PubMed
  5. Akiyama C, et al. 2019. J Immunol. 203:835. PubMed
  6. Bergfeld A, et al. 2017. Front Microbiol. 0.919444444. PubMed
  7. Liu CJ, et al. 2020. Neuro Oncol. 22:1276. PubMed
  8. Collin R, et al. 2020. J Immunol. 205:133. PubMed
  9. Malinczak CA, et al. 2021. J Immunol. 206:1315. PubMed
  10. Li H, et al. 2022. Cancer Cell. 40:36. PubMed
  11. Koenig A, et al. 2022. Front Immunol. 12:791100. PubMed
  12. Zhu M, et al. 2022. Front Immunol. 13:1019248. PubMed
  13. Briukhovetska D, et al. 2023. Immunity. 56:143. PubMed
  14. Zhang J, et al. 2023. Int J Nanomedicine. 18:209. PubMed
  15. Elliot TAE, et al. 2022. Discov Immunol. 1:kyac009. PubMed
  16. Schick J, et al. 2023. Elife. 12: . PubMed
  17. Shirai T, et al. 2022. Cancer Sci. 113:3710. PubMed
  18. Giampaolo S, et al. 2023. iScience. 26:106234. PubMed
  19. Do-Thi VA, et al. 2023. Cancer Res Commun. 3:80. PubMed
  20. Kobayashi A, et al. 2021. Front Immunol. 12:650856. PubMed
  21. Paterson MJ, et al. 2020. PLoS Pathog. 16:e1008733. PubMed
  22. Tian J, et al. 2021. Autophagy. 17:2586. PubMed
  23. Tersteegen A, et al. 2021. Infect Immun. 89:. PubMed
  24. Sandu I, et al. 2020. Nat Commun. 11:4454. PubMed
  25. Krovi SH, et al. 2019. Proc Natl Acad Sci U S A. 116:22252. PubMed
  26. Biljes D, et al. 2017. EXCLI J. 0.86875. PubMed
  27. Chartrand K, et al. 2018. Front Immunol. 1.642361111. PubMed
  28. Kondo H, et al. 2020. J Biol Chem. 295:1658. PubMed
  29. Wan Mohd Zawawi WFA, et al. 2021. Sci Rep. 11:10278. PubMed
  30. Boyd DF, et al. 2020. Nature. 587:466. PubMed
  31. Field CS, et al. 2018. Oncoimmunology. 7:e1376154. PubMed
  32. Namavari A, et al. 2012. Invest Ophthalmol Vis Sci . 53:4575. PubMed
  33. Goel S, et al. 2017. Nature. 548:471. PubMed
  34. Prado C, et al. 2021. J Neuroinflammation. 18:292. PubMed
  35. Uzhachenko RV, et al. 2021. Cell Reports. 35(1):108944. PubMed
  36. Chen L, et al. 2019. Nat Commun. 3.553472222. PubMed
  37. Sanctuary MR, et al. 2019. Mucosal Immunol. 0.638888889. PubMed
  38. Carpenter SM, et al. 2017. PLoS Pathog. 13:e1006704. PubMed
  39. Wong E, et al. 2019. Cell Rep. 29:3047. PubMed
  40. Crawford G, et al. 2018. Nat Immunol. 1.388194444. PubMed
  41. Cao Q, et al. 2018. Am J Physiol Renal Physiol. 314:F561. PubMed
  42. Oghumu S, et al. 2019. J Immunol. 203:789. PubMed
  43. Liang W, et al. 2022. Methods Mol Biol. 2574:221. PubMed
  44. Nagatake T, et al. 2022. Mucosal Immunol. 15:289. PubMed
  45. McLane LM, et al. 2021. Cell Reports. 35(6):109120. PubMed
  46. Niss Arfelt K, et al. 2017. Blood. 129:866. PubMed
  47. Arimura K, et al. 2017. Mucosal Immunol. 1.08125. PubMed
  48. Zhou AC, et al. 2017. Front Immunol. 1.136111111. PubMed
  49. Willimsky G, et al. 2021. Elife. 10:. PubMed
  50. Quintana E, et al. 2020. Cancer Res. 80:2889. PubMed
  51. Jennings EK, et al. 2021. STAR Protocols. 2(1):100284. PubMed
  52. Lu SX, et al. 2021. Cell. . PubMed
  53. Liu W, et al. 2021. Stem Cell Res Ther. 12:153. PubMed
  54. Joseph R, et al. 2021. Br J Cancer. 125:176. PubMed
  55. Edenborough KM, et al. 2019. Front Immunol. 10:2414. PubMed
  56. McLeod RL, et al. 2018. Oncotarget. 9:34459. PubMed
  57. Robert S, et al. 2018. Bone Marrow Transplant. 53:807. PubMed
  58. Morabito KM, et al. 2017. Mucosal Immunol. 0.795138889. PubMed
  59. Rissiek B, et al. 2017. Sci Rep. . 10.1038/s41598-017-16613-w. PubMed
  60. Delgobo M, et al. 2021. Front Immunol. 12:584538. PubMed
  61. Peng V, et al. 2020. J Biol Chem. 295:14866. PubMed
  62. Tanaka Y, et al. 2021. Int J Mol Sci. 22:. PubMed
  63. Muhammad F, et al. 2020. Front Immunol. 975:11. PubMed
  64. Yi M, et al. 2021. J Hematol Oncol. 14:27. PubMed
  65. Rao TN, et al. 2020. J Immunol. 204:2600. PubMed
  66. Perchonock C, et al. 2006. Mol Cell Biol . 26:6005. PubMed
  67. Guo Y, et al. 2008. Blood. 112:480. PubMed
  68. Sekiya T et al. 2018. Cell reports. 24(6):1627-1638 . PubMed
  69. Lyon de Ana C, et al. 2019. J Immunol. 202:1112. PubMed
  70. Wu P et al. 2019. Molecular cell. 73(5):1015-1027 . PubMed
  71. Tuzlak S, et al. 2017. Cell Death Differ. 24:523. PubMed
  72. Doorduijn EM, et al. 2018. Front Immunol. 0.416666667. PubMed
  73. Baluk P, et al. 2020. Am J Pathol. 190:2355. PubMed
  74. Mullins GN, et al. 2020. Sci Rep. 10:21994. PubMed
  75. Hilligan KL, et al. 2020. Nat Commun. 11:5637. PubMed
  76. Suzuki Y, et al. 2021. FEBS Open Bio. 11:2619. PubMed
  77. El Maï M, et al. 2021. Cancers (Basel). 13:. PubMed
  78. Hanoteau A, et al. 2019. J Immunother Cancer. 7:10. PubMed
  79. Stacey MA, et al. 2017. J Clin Invest. 127:1463. PubMed
  80. Duc D et al. 2019. Cell Rep. 29(2):378-390 . PubMed
  81. Xu L et al. 2017. Immunity. 47(3):538-551 . PubMed
  82. Zhang P, et al. 2022. BMC Med. 20:435. PubMed
  83. McCully M, et al. 2015. J Immunol. 195: 96 - 104. PubMed
  84. Bremser A, et al. 2015. PLoS One. 10: 0137393. PubMed
  85. Gartlan KH, et al. 2019. Blood Adv. 2.110416667. PubMed
  86. Abboud G, et al. 2018. Front Immunol. 9:1973. PubMed
  87. Chen Z et al. 2019. Immunity. 51(5):840-855 . PubMed
  88. Imani J, et al. 2021. JCI Insight. 6:. PubMed
  89. Xie D, et al. 2020. Eur J Immunol. 50:1729. PubMed
  90. Reed J, et al. 2020. Bio Protoc. 10:e3607. PubMed
  91. Morales-Mantilla DE, et al. 2022. Elife. 11:. PubMed
  92. Brown IK, et al. 2021. PLoS Pathog. 17:e1009602. PubMed
  93. Cain MP, et al. 2020. Dis Model Mech. 13:00. PubMed
  94. Takushi SE, et al. 2020. Hum Gene Ther. 31:626. PubMed
  95. Borges TJ, et al. 2018. Nat Commun. 9:3482. PubMed
  96. Di Martino L, et al. 2021. Cell Mol Gastroenterol Hepatol. 13:901. PubMed
  97. James OJ, et al. 2021. Nat Commun. 12:4290. PubMed
  98. Sharabi A, et al. 2019. JCI Insight. 4:e126294. PubMed
  99. Du J, et al. 2018. AMB Express. 8:158. PubMed
  100. Majer O, et al. 2019. Nature. 575:366. PubMed
  101. Won HY, et al. 2017. Sci Rep. 7:16946. PubMed
  102. Van De Velde LA, et al. 2017. J Biol Chem. 292:15:00. PubMed
  103. Scholz T, et al. 2017. PLoS One. 12:e0182646. PubMed
  104. Sprouse ML, et al. 2018. JCI Insight. 3:e97322. PubMed
  105. Lee JY, et al. 2018. Front Immunol. 0.678472222. PubMed
  106. Sun L, et al. 2022. Front Immunol. 13:823853. PubMed
  107. Wu G, et al. 2022. Wellcome Open Res. 6:134. PubMed
  108. Otsuka S, et al. 2021. J Clin Invest. 131:. PubMed
  109. Schuler CF, et al. 2020. Allergy. 75:2279. PubMed
  110. Yoon S, et al. 2020. Antioxidants (Basel). 10:. PubMed
  111. Tao H, et al. 2021. Front Immunol. 12:623280. PubMed
  112. Hsieh WC, et al. 2020. JCI Insight. 5:00. PubMed
  113. Sharma M, et al. 2020. Circ Res. 127:335. PubMed
  114. Seo N, et al. 2018. Nat Commun. 9:435. PubMed
  115. Parzmair GP, et al. 2017. J Leukoc Biol. 101:407. PubMed
  116. Kälin S et al. 2017. Cell metabolism. 26(3):475-492 . PubMed
  117. Simula L et al. 2018. Cell reports. 25(11):3059-3073 . PubMed
  118. Nagatake T, et al. 2018. Int Immunol. 30:471. PubMed
  119. Hao Y, et al. 2018. Front Immunol. 9:1127. PubMed
  120. Ma VP, et al. 2022. Sci Adv. 8:eabg4485. PubMed
  121. Li Z, et al. 2021. MBio. 12:e0254221. PubMed
  122. Ejima R, et al. 2021. Nutrients. 13:. PubMed
  123. Becker W, et al. 2021. J Crohns Colitis. 15:1032. PubMed
  124. Chen HW, et al. 2021. Biomedicines. 9:. PubMed
  125. Sandy A, et al. 2013. J Immunol. 190:5818. PubMed
  126. Klein JC, et al. 2017. Nat Commun. 8:14600. PubMed
  127. Baluk P, et al. 2018. Methods Mol Biol. 1846:161. PubMed
  128. Katagiri T, et al. 2019. Mucosal Immunol. 12:p1104. PubMed
  129. Wang HC, et al. 2017. J Immunol. 198:3149. PubMed
  130. Parigi SM, et al. 2018. Sci Rep. 0.440277778. PubMed
  131. Shiozawa S, et al. 2022. iScience. 25:103537. PubMed
  132. Wu Y, et al. 2021. J Clin Invest. 131:. PubMed
  133. Rigo MM, et al. 2020. FEBS J. :. PubMed
  134. Sripada A, et al. 2021. PLoS Biol. 19:e3001063. PubMed
  135. Spranger S, et al. 2017. Cancer Cell. 31:711. PubMed
  136. Wang W, et al. 2018. J Vasc Surg. 68:1538. PubMed
  137. Nagatake T, et al. 2018. J Allergy Clin Immunol. 142:470. PubMed
  138. Lee J, et al. 2020. Cells. 9:. PubMed
  139. Seo SU, et al. 2021. Front Immunol. 12:697162. PubMed
  140. Goh W, et al. 2020. Cell Rep. 33:108285. PubMed
  141. Teijeira A, et al. 2018. Cancer Immunol Res. 6:798. PubMed
  142. Jiao S, et al. 2020. Cell. 179(5):1177-1190.e13.. PubMed
  143. Link MA, et al. 2017. PLoS One. 12:e0184320. PubMed
  144. Aguilar OA, et al. 2020. J Immunol. 205:1709. PubMed
  145. Taylor MD, et al. 2020. Front Immunol. 11:1946. PubMed
  146. Kissiov DU, et al. 2022. Elife. 11:. PubMed
  147. Yoon S, et al. 2022. Nat Commun. 13:1602. PubMed
  148. Fernández-Orth J, et al. 2020. Eur J Immunol. . PubMed
  149. Wagner AK, et al. 2017. Nat Commun. 8:15627. PubMed
  150. Stelekati E, et al. 2018. Cell Rep. 2.445833333. PubMed
  151. Cui X, et al. 2017. J Immunol. 199:4066. PubMed
  152. Simmons S et al. 2019. Elife. 8 pii: e41239. PubMed
  153. Niven J, et al. 2019. Cell Rep. 28:21. PubMed
  154. Coley WD et al. 2018. F1000Research. 2018 Mar 14 [revised 2018 Jan 1] 0.5125. PubMed
  155. Koch K, et al. 2022. Int J Mol Sci. 23:. PubMed
  156. Yang H, et al. 2022. Cell Death Discov. 8:183. PubMed
  157. Qiu Z, et al. 2022. Cancer Discov. 12:502. PubMed
  158. Sun Y, et al. 2021. Nat Commun. 12:5147. PubMed
  159. Lin Z, et al. 2021. Stem Cells. 39:240. PubMed
  160. Chen Z, et al. 2021. Cell. 184(5):1262-1280.e22. PubMed
  161. Gaspar M, et al. 2020. Cancer Immunol Res. 0.875694444. PubMed
  162. Afzali B, et al. 2017. Nat Immunol. 18:813. PubMed
  163. Cohen MA, et al. 2020. Cell Stem Cell. 26(4):579-592. PubMed
  164. Genoud V, et al. 2018. Oncoimmunology. 7:e1501137. PubMed
  165. Gaya M et al. 2018. Cell. 172(3):517-533 . PubMed
  166. Schnoegl D, et al. 2022. Front Immunol. 13:909270. PubMed
  167. Dey P, et al. 2020. Cancer Discov. 10:608. PubMed
  168. Perchonock C, et al. 2007. J Immunol. 179:1768. PubMed
  169. Cole C, et al. 2018. Nucleic Acids Res. 46:e62. PubMed
  170. Abe Y, et al. 2017. Biochem Biophys Rep. 0.543055556. PubMed
  171. Nakamura K, et al. 2018. Cancer Cell. 33:634. PubMed
  172. Lin J, et al. 2017. Nat Commun. . 10.1038/s41467-017-01477-5. PubMed
  173. Taylor MD, et al. 2020. Front Immunol. 11:563402. PubMed
  174. Nagatake T, et al. 2021. Int Immunol. 33:171. PubMed
  175. Sasai M, et al. 2021. J Exp Med. 218:. PubMed
  176. Wang G, et al. 2015. PLoS One. 10:121968. PubMed
  177. Kojima T, et al. 2016. Sci Rep. 6:36457. PubMed
  178. Khameneh HJ, et al. 2017. J Immunol. 198:196. PubMed
  179. Wang N, et al. 2020. Front Immunol. 1.765972222. PubMed
  180. An Y et al. 2018. Cell reports. 25(3):702-714 . PubMed
  181. Kikuchi K, et al. 2018. J Immunol. 201:635. PubMed
  182. Akkaya B, et al. 2018. J Immunol. 201:3294. PubMed
  183. Bordoloi D, et al. 2021. Genes Cancer. 12:51. PubMed
  184. Wang W, et al. 2022. Nat Commun. 13:4495. PubMed
  185. Katsuyama T, et al. 2021. Cell Reports. 36(1):109339. PubMed
  186. Kästle M, et al. 2020. Cell Commun Signal. 183:18. PubMed
  187. Fritz Y, et al. 2017. J Invest Dermatol. 137:696. PubMed
  188. Umeda M, et al. 2021. Proc Natl Acad Sci U S A. 118:. PubMed
  189. Prabakaran T, et al. 2021. EBioMedicine. 66:103314. PubMed
  190. Yamazaki K, et al. 2022. Sci Rep. 12:3242. PubMed
  191. Chen YH, et al. 2022. Arthritis Res Ther. 24:27. PubMed
  192. Sutiwisesak R, et al. 2020. PLoS Pathog. 16:e1009000. PubMed
  193. Xia L, et al. 2021. Cancer Immunol Res. 9:707. PubMed
  194. Galeano Nio JL, et al. 2020. eLife. 9:00. PubMed
  195. Kim K, et al. 2016. PLoS One. 11: 0148576. PubMed
  196. Chemnitz J, et al. 2019. Sci Rep. 3.745138889. PubMed
  197. Arnold IC, et al. 2019. PLoS Pathog. 15:e1007866. PubMed
  198. Wolf Y, et al. 2017. J Exp Med. 214:905. PubMed
  199. Akiyama C, et al. 2019. J Immunol. 203:835. PubMed
  200. Bergfeld A, et al. 2017. Front Microbiol. 0.919444444. PubMed
  201. Liu CJ, et al. 2020. Neuro Oncol. 22:1276. PubMed
  202. Collin R, et al. 2020. J Immunol. 205:133. PubMed
  203. Malinczak CA, et al. 2021. J Immunol. 206:1315. PubMed
  204. Li H, et al. 2022. Cancer Cell. 40:36. PubMed
  205. Koenig A, et al. 2022. Front Immunol. 12:791100. PubMed
  206. Zhu M, et al. 2022. Front Immunol. 13:1019248. PubMed
  207. Briukhovetska D, et al. 2023. Immunity. 56:143. PubMed
  208. Zhang J, et al. 2023. Int J Nanomedicine. 18:209. PubMed
  209. Elliot TAE, et al. 2022. Discov Immunol. 1:kyac009. PubMed
  210. Schick J, et al. 2023. Elife. 12: . PubMed
  211. Shirai T, et al. 2022. Cancer Sci. 113:3710. PubMed
  212. Giampaolo S, et al. 2023. iScience. 26:106234. PubMed
  213. Do-Thi VA, et al. 2023. Cancer Res Commun. 3:80. PubMed
  214. Kobayashi A, et al. 2021. Front Immunol. 12:650856. PubMed
  215. Paterson MJ, et al. 2020. PLoS Pathog. 16:e1008733. PubMed
  216. Tian J, et al. 2021. Autophagy. 17:2586. PubMed
  217. Tersteegen A, et al. 2021. Infect Immun. 89:. PubMed
  218. Sandu I, et al. 2020. Nat Commun. 11:4454. PubMed
  219. Krovi SH, et al. 2019. Proc Natl Acad Sci U S A. 116:22252. PubMed
  220. Biljes D, et al. 2017. EXCLI J. 0.86875. PubMed
  221. Chartrand K, et al. 2018. Front Immunol. 1.642361111. PubMed
  222. Kondo H, et al. 2020. J Biol Chem. 295:1658. PubMed
  223. Wan Mohd Zawawi WFA, et al. 2021. Sci Rep. 11:10278. PubMed
  224. Boyd DF, et al. 2020. Nature. 587:466. PubMed
  225. Field CS, et al. 2018. Oncoimmunology. 7:e1376154. PubMed
  226. Namavari A, et al. 2012. Invest Ophthalmol Vis Sci . 53:4575. PubMed
  227. Goel S, et al. 2017. Nature. 548:471. PubMed
  228. Prado C, et al. 2021. J Neuroinflammation. 18:292. PubMed
  229. Uzhachenko RV, et al. 2021. Cell Reports. 35(1):108944. PubMed
  230. Chen L, et al. 2019. Nat Commun. 3.553472222. PubMed
  231. Sanctuary MR, et al. 2019. Mucosal Immunol. 0.638888889. PubMed
  232. Carpenter SM, et al. 2017. PLoS Pathog. 13:e1006704. PubMed
  233. Wong E, et al. 2019. Cell Rep. 29:3047. PubMed
  234. Crawford G, et al. 2018. Nat Immunol. 1.388194444. PubMed
  235. Cao Q, et al. 2018. Am J Physiol Renal Physiol. 314:F561. PubMed
  236. Oghumu S, et al. 2019. J Immunol. 203:789. PubMed
  237. Liang W, et al. 2022. Methods Mol Biol. 2574:221. PubMed
  238. Nagatake T, et al. 2022. Mucosal Immunol. 15:289. PubMed
  239. McLane LM, et al. 2021. Cell Reports. 35(6):109120. PubMed
  240. Niss Arfelt K, et al. 2017. Blood. 129:866. PubMed
  241. Arimura K, et al. 2017. Mucosal Immunol. 1.08125. PubMed
  242. Zhou AC, et al. 2017. Front Immunol. 1.136111111. PubMed
  243. Willimsky G, et al. 2021. Elife. 10:. PubMed
  244. Quintana E, et al. 2020. Cancer Res. 80:2889. PubMed
  245. Jennings EK, et al. 2021. STAR Protocols. 2(1):100284. PubMed
  246. Lu SX, et al. 2021. Cell. . PubMed
  247. Liu W, et al. 2021. Stem Cell Res Ther. 12:153. PubMed
  248. Joseph R, et al. 2021. Br J Cancer. 125:176. PubMed
  249. Edenborough KM, et al. 2019. Front Immunol. 10:2414. PubMed
  250. McLeod RL, et al. 2018. Oncotarget. 9:34459. PubMed
  251. Robert S, et al. 2018. Bone Marrow Transplant. 53:807. PubMed
  252. Morabito KM, et al. 2017. Mucosal Immunol. 0.795138889. PubMed
  253. Rissiek B, et al. 2017. Sci Rep. . 10.1038/s41598-017-16613-w. PubMed
  254. Delgobo M, et al. 2021. Front Immunol. 12:584538. PubMed
  255. Peng V, et al. 2020. J Biol Chem. 295:14866. PubMed
  256. Tanaka Y, et al. 2021. Int J Mol Sci. 22:. PubMed
  257. Muhammad F, et al. 2020. Front Immunol. 975:11. PubMed
  258. Yi M, et al. 2021. J Hematol Oncol. 14:27. PubMed
  259. Rao TN, et al. 2020. J Immunol. 204:2600. PubMed
  260. Perchonock C, et al. 2006. Mol Cell Biol . 26:6005. PubMed
  261. Guo Y, et al. 2008. Blood. 112:480. PubMed
  262. Sekiya T et al. 2018. Cell reports. 24(6):1627-1638 . PubMed
  263. Lyon de Ana C, et al. 2019. J Immunol. 202:1112. PubMed
  264. Wu P et al. 2019. Molecular cell. 73(5):1015-1027 . PubMed
  265. Tuzlak S, et al. 2017. Cell Death Differ. 24:523. PubMed
  266. Doorduijn EM, et al. 2018. Front Immunol. 0.416666667. PubMed
  267. Baluk P, et al. 2020. Am J Pathol. 190:2355. PubMed
  268. Mullins GN, et al. 2020. Sci Rep. 10:21994. PubMed
  269. Hilligan KL, et al. 2020. Nat Commun. 11:5637. PubMed
  270. Suzuki Y, et al. 2021. FEBS Open Bio. 11:2619. PubMed
  271. El Maï M, et al. 2021. Cancers (Basel). 13:. PubMed
  272. Hanoteau A, et al. 2019. J Immunother Cancer. 7:10. PubMed
  273. Stacey MA, et al. 2017. J Clin Invest. 127:1463. PubMed
  274. Duc D et al. 2019. Cell Rep. 29(2):378-390 . PubMed
  275. Xu L et al. 2017. Immunity. 47(3):538-551 . PubMed
  276. Zhang P, et al. 2022. BMC Med. 20:435. PubMed
  277. McCully M, et al. 2015. J Immunol. 195: 96 - 104. PubMed
  278. Bremser A, et al. 2015. PLoS One. 10: 0137393. PubMed
  279. Gartlan KH, et al. 2019. Blood Adv. 2.110416667. PubMed
  280. Abboud G, et al. 2018. Front Immunol. 9:1973. PubMed
  281. Chen Z et al. 2019. Immunity. 51(5):840-855 . PubMed
  282. Imani J, et al. 2021. JCI Insight. 6:. PubMed
  283. Xie D, et al. 2020. Eur J Immunol. 50:1729. PubMed
  284. Reed J, et al. 2020. Bio Protoc. 10:e3607. PubMed
  285. Morales-Mantilla DE, et al. 2022. Elife. 11:. PubMed
  286. Brown IK, et al. 2021. PLoS Pathog. 17:e1009602. PubMed
  287. Cain MP, et al. 2020. Dis Model Mech. 13:00. PubMed
  288. Takushi SE, et al. 2020. Hum Gene Ther. 31:626. PubMed
  289. Borges TJ, et al. 2018. Nat Commun. 9:3482. PubMed
  290. Di Martino L, et al. 2021. Cell Mol Gastroenterol Hepatol. 13:901. PubMed
  291. James OJ, et al. 2021. Nat Commun. 12:4290. PubMed
  292. Sharabi A, et al. 2019. JCI Insight. 4:e126294. PubMed
  293. Du J, et al. 2018. AMB Express. 8:158. PubMed
  294. Majer O, et al. 2019. Nature. 575:366. PubMed
  295. Won HY, et al. 2017. Sci Rep. 7:16946. PubMed
  296. Van De Velde LA, et al. 2017. J Biol Chem. 292:15:00. PubMed
  297. Scholz T, et al. 2017. PLoS One. 12:e0182646. PubMed
  298. Sprouse ML, et al. 2018. JCI Insight. 3:e97322. PubMed
  299. Lee JY, et al. 2018. Front Immunol. 0.678472222. PubMed
  300. Sun L, et al. 2022. Front Immunol. 13:823853. PubMed
  301. Wu G, et al. 2022. Wellcome Open Res. 6:134. PubMed
  302. Otsuka S, et al. 2021. J Clin Invest. 131:. PubMed
  303. Schuler CF, et al. 2020. Allergy. 75:2279. PubMed
  304. Yoon S, et al. 2020. Antioxidants (Basel). 10:. PubMed
  305. Tao H, et al. 2021. Front Immunol. 12:623280. PubMed
  306. Hsieh WC, et al. 2020. JCI Insight. 5:00. PubMed
  307. Sharma M, et al. 2020. Circ Res. 127:335. PubMed
  308. Seo N, et al. 2018. Nat Commun. 9:435. PubMed
  309. Parzmair GP, et al. 2017. J Leukoc Biol. 101:407. PubMed
  310. Kälin S et al. 2017. Cell metabolism. 26(3):475-492 . PubMed
  311. Simula L et al. 2018. Cell reports. 25(11):3059-3073 . PubMed
  312. Nagatake T, et al. 2018. Int Immunol. 30:471. PubMed
  313. Hao Y, et al. 2018. Front Immunol. 9:1127. PubMed
  314. Ma VP, et al. 2022. Sci Adv. 8:eabg4485. PubMed
  315. Li Z, et al. 2021. MBio. 12:e0254221. PubMed
  316. Ejima R, et al. 2021. Nutrients. 13:. PubMed
  317. Becker W, et al. 2021. J Crohns Colitis. 15:1032. PubMed
  318. Chen HW, et al. 2021. Biomedicines. 9:. PubMed
  319. Sandy A, et al. 2013. J Immunol. 190:5818. PubMed
  320. Klein JC, et al. 2017. Nat Commun. 8:14600. PubMed
  321. Baluk P, et al. 2018. Methods Mol Biol. 1846:161. PubMed
  322. Katagiri T, et al. 2019. Mucosal Immunol. 12:p1104. PubMed
  323. Wang HC, et al. 2017. J Immunol. 198:3149. PubMed
  324. Parigi SM, et al. 2018. Sci Rep. 0.440277778. PubMed
  325. Shiozawa S, et al. 2022. iScience. 25:103537. PubMed
  326. Wu Y, et al. 2021. J Clin Invest. 131:. PubMed
  327. Rigo MM, et al. 2020. FEBS J. :. PubMed
  328. Sripada A, et al. 2021. PLoS Biol. 19:e3001063. PubMed
  329. Spranger S, et al. 2017. Cancer Cell. 31:711. PubMed
  330. Wang W, et al. 2018. J Vasc Surg. 68:1538. PubMed
  331. Nagatake T, et al. 2018. J Allergy Clin Immunol. 142:470. PubMed
  332. Lee J, et al. 2020. Cells. 9:. PubMed
  333. Seo SU, et al. 2021. Front Immunol. 12:697162. PubMed
  334. Goh W, et al. 2020. Cell Rep. 33:108285. PubMed
  335. Teijeira A, et al. 2018. Cancer Immunol Res. 6:798. PubMed
  336. Jiao S, et al. 2020. Cell. 179(5):1177-1190.e13.. PubMed
  337. Link MA, et al. 2017. PLoS One. 12:e0184320. PubMed
  338. Aguilar OA, et al. 2020. J Immunol. 205:1709. PubMed
  339. Taylor MD, et al. 2020. Front Immunol. 11:1946. PubMed
  340. Kissiov DU, et al. 2022. Elife. 11:. PubMed
  341. Yoon S, et al. 2022. Nat Commun. 13:1602. PubMed
  342. Fernández-Orth J, et al. 2020. Eur J Immunol. . PubMed
  343. Wagner AK, et al. 2017. Nat Commun. 8:15627. PubMed
  344. Stelekati E, et al. 2018. Cell Rep. 2.445833333. PubMed
  345. Cui X, et al. 2017. J Immunol. 199:4066. PubMed
  346. Simmons S et al. 2019. Elife. 8 pii: e41239. PubMed
  347. Niven J, et al. 2019. Cell Rep. 28:21. PubMed
  348. Coley WD et al. 2018. F1000Research. 2018 Mar 14 [revised 2018 Jan 1] 0.5125. PubMed
  349. Koch K, et al. 2022. Int J Mol Sci. 23:. PubMed
  350. Yang H, et al. 2022. Cell Death Discov. 8:183. PubMed
  351. Qiu Z, et al. 2022. Cancer Discov. 12:502. PubMed
  352. Sun Y, et al. 2021. Nat Commun. 12:5147. PubMed
  353. Lin Z, et al. 2021. Stem Cells. 39:240. PubMed
  354. Chen Z, et al. 2021. Cell. 184(5):1262-1280.e22. PubMed
  355. Gaspar M, et al. 2020. Cancer Immunol Res. 0.875694444. PubMed
  356. Afzali B, et al. 2017. Nat Immunol. 18:813. PubMed
  357. Cohen MA, et al. 2020. Cell Stem Cell. 26(4):579-592. PubMed
  358. Genoud V, et al. 2018. Oncoimmunology. 7:e1501137. PubMed
  359. Gaya M et al. 2018. Cell. 172(3):517-533 . PubMed
  360. Schnoegl D, et al. 2022. Front Immunol. 13:909270. PubMed
  361. Dey P, et al. 2020. Cancer Discov. 10:608. PubMed
  362. Perchonock C, et al. 2007. J Immunol. 179:1768. PubMed
  363. Cole C, et al. 2018. Nucleic Acids Res. 46:e62. PubMed
  364. Abe Y, et al. 2017. Biochem Biophys Rep. 0.543055556. PubMed
  365. Nakamura K, et al. 2018. Cancer Cell. 33:634. PubMed
  366. Lin J, et al. 2017. Nat Commun. . 10.1038/s41467-017-01477-5. PubMed
  367. Taylor MD, et al. 2020. Front Immunol. 11:563402. PubMed
  368. Nagatake T, et al. 2021. Int Immunol. 33:171. PubMed
  369. Sasai M, et al. 2021. J Exp Med. 218:. PubMed
  370. Wang G, et al. 2015. PLoS One. 10:121968. PubMed
  371. Kojima T, et al. 2016. Sci Rep. 6:36457. PubMed
  372. Khameneh HJ, et al. 2017. J Immunol. 198:196. PubMed
  373. Wang N, et al. 2020. Front Immunol. 1.765972222. PubMed
  374. An Y et al. 2018. Cell reports. 25(3):702-714 . PubMed
  375. Kikuchi K, et al. 2018. J Immunol. 201:635. PubMed
  376. Akkaya B, et al. 2018. J Immunol. 201:3294. PubMed
  377. Bordoloi D, et al. 2021. Genes Cancer. 12:51. PubMed
  378. Wang W, et al. 2022. Nat Commun. 13:4495. PubMed
  379. Katsuyama T, et al. 2021. Cell Reports. 36(1):109339. PubMed
  380. Kästle M, et al. 2020. Cell Commun Signal. 183:18. PubMed
  381. Fritz Y, et al. 2017. J Invest Dermatol. 137:696. PubMed
  382. Umeda M, et al. 2021. Proc Natl Acad Sci U S A. 118:. PubMed
  383. Prabakaran T, et al. 2021. EBioMedicine. 66:103314. PubMed
  384. Yamazaki K, et al. 2022. Sci Rep. 12:3242. PubMed
  385. Chen YH, et al. 2022. Arthritis Res Ther. 24:27. PubMed
  386. Sutiwisesak R, et al. 2020. PLoS Pathog. 16:e1009000. PubMed
  387. Xia L, et al. 2021. Cancer Immunol Res. 9:707. PubMed
  388. Galeano Nio JL, et al. 2020. eLife. 9:00. PubMed
RRID
AB_312666 (BioLegend Cat. No. 100301)
AB_312667 (BioLegend Cat. No. 100302)

Antigen Details

Structure
Ig superfamily, forms CD3/TCR complex with CD3δ, γ and ζ subunits and TCR (α/β and γ/δ), 20 kD
Distribution

Thymocytes (differentiation dependent), mature T cells, NK-T cells

Function
TCR signal transduction, T cell activation, antigen recognition
Ligand/Receptor
Peptide antigen/MHC-complex
Cell Type
NKT cells, T cells, Thymocytes, Tregs
Biology Area
Immunology
Molecular Family
CD Molecules, TCRs
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Davis MM. 1990. Annu. Rev. Biochem. 59:475.
3. Weiss A, et al. 1994. Cell 76:263.

Gene ID
12501 View all products for this Gene ID
UniProt
View information about CD3epsilon on UniProt.org

Other Formats

View All CD3ε Reagents Request Custom Conjugation
Description Clone Applications
PE/Cyanine7 anti-mouse CD3ε 145-2C11 FC
Purified anti-mouse CD3ε (Maxpar® Ready) 145-2C11 FC,CyTOF®
PE/Dazzle™ 594 anti-mouse CD3ε 145-2C11 FC
Brilliant Violet 605™ anti-mouse CD3ε 145-2C11 FC
Brilliant Violet 711™ anti-mouse CD3ε 145-2C11 FC
Brilliant Violet 785™ anti-mouse CD3ε 145-2C11 FC
Brilliant Violet 510™ anti-mouse CD3ε 145-2C11 FC
APC/Fire™ 750 anti-mouse CD3ε 145-2C11 FC
GoInVivo™ Purified anti-mouse CD3ε 145-2C11 FC
APC anti-mouse CD3ε 145-2C11 FC
Biotin anti-mouse CD3ε 145-2C11 FC,IHC-F
FITC anti-mouse CD3ε 145-2C11 FC
PE anti-mouse CD3ε 145-2C11 FC
PE/Cyanine5 anti-mouse CD3ε 145-2C11 FC
Purified anti-mouse CD3ε 145-2C11 FC,IHC-F,IP,Activ,Block,WB,ICC
Alexa Fluor® 488 anti-mouse CD3ε 145-2C11 FC
Alexa Fluor® 647 anti-mouse CD3ε 145-2C11 FC,IHC-F,3D IHC
PerCP anti-mouse CD3ε 145-2C11 FC
PerCP/Cyanine5.5 anti-mouse CD3ε 145-2C11 FC
APC/Cyanine7 anti-mouse CD3ε 145-2C11 FC
Pacific Blue™ anti-mouse CD3ε 145-2C11 FC
Ultra-LEAF™ Purified anti-mouse CD3ε 145-2C11 FC,IHC-F,IP,Activ,Block,WB,ICC
Brilliant Violet 421™ anti-mouse CD3ε 145-2C11 FC,ICC
Spark YG™ 593 anti-mouse CD3 145-2C11 FC
PerCP/Fire™ 780 anti-mouse CD3ε 145-2C11 FC
Brilliant Violet 650™ anti-mouse CD3ε 145-2C11 FC
Brilliant Violet 750™ anti-mouse CD3ε 145-2C11 FC
APC/Fire™ 810 anti-mouse CD3ε Antibody 145-2C11 FC
Spark YG™ 581 anti-mouse CD3ε (Flexi-Fluor™) 145-2C11 FC
Spark NIR™ 685 anti-mouse CD3ε (Flexi-Fluor™) Antibody 145-2C11 FC
PE/Fire™ 640 anti-mouse CD3ε 145-2C11
Go To Top Version: 2    Revision Date: 10.17.2017

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account